During the past decade, Psychiatric and Behavioral Solutions conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 13 clinical trials were completed, i.e. on average, 92.9% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 11 clinical trials were completed. i.e. 1100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Psychiatric and Behavioral Solutions" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 4 trials, followed by "Rhodes Pharmaceuticals, L.P." with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Alcobra Ltd." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Psychiatric and Behavioral Solutions" #1 collaborator was "Purdue Pharma LP" with 2 trials as a collaborator, "Otsuka America Pharmaceutical" with 1 trials as a collaborator and "Purdue Pharma, Canada" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Psychiatric and Behavioral Solutions" are "ADHD" (4 trials), "Depressive Disorder, Major" (4 trials), "Schizophrenia" (3 trials), "Depression" (2 trials) and "Attention Deficit Hyperactivity Disorder (ADHD)" (1 trials). Many other conditions were trialed in "Psychiatric and Behavioral Solutions" in a lesser frequency.

Most popular intervention types in "Psychiatric and Behavioral Solutions" are "Drug" (18 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Rapastinel" (4 trials), "BMS-820836" (2 trials), "PRC-063 25 mg" (2 trials) and "PRC-063 45 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Psychiatric and Behavioral Solutions" are 19 trials for "All" genders.

Currently, there are NaN active trials in "Psychiatric and Behavioral Solutions". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Psychiatric and Behavioral Solutions, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Psychiatric and Behavioral Solutions, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".